Photo

Photo detail

Saunders

Stories this photo appears in:

Allergan Q3 Beats, Street Not Impressed

Allergan PLC grew sales by 11% in the third quarter, led once again by its flagship drug BOTOX.

Tease photo

Allergan Plans To Appeal Restasis Decision

Allergan PLC raised eyebrows last month when it announced its patent deal with an American Indian tribe in New York, transferring the rights for its eye drug Restasis to the Saint Regis Mohawk Tribe.

Tease photo

Allergan Q2 Strong, Raises Guidance

Allergan plc reported revenue of $4 billion for its most recent quarter, up 9% year-over-year and driven primarily by its Irvine-based aesthetic portfolio that includes Botox and dermal filler Juvederm.

Tease photo

Allergan in $2.9B Aesthetics Buy

Allergan plc bought LifeCell Corp., which develops aesthetic and regenerative medicine used in plastic surgery, for $2.9 billion, in a deal expected to close in the first quarter.

Tease photo

Allergan Expands Board

Allergan Plc. said it appointed Adriane Brown to its board of directors, effective in February. Brown is president and chief operating officer of Intellectual Ventures LLC, a privately held company in Bellevue, Wash., that provides invention-related services and buys patents.

Tease photo

Allergan’s Saunders Adds Chairman Role

Allergan Plc President and Chief Executive Brent Saunders is now also Chairman of the drug maker’s board of directors, replacing Paul Bisaro.

Tease photo

Allergan Still on Hunt for Deals

Allergan PLC Chief Executive Brent Saunders said today that the drug maker will continue to seek “growth pharma” deals—including possible acquisitions that would complement its Irvine hub for Botox, ophthalmology and medical aesthetics—after the termination of its $160 billion mega-deal with Pfizer Inc.

Tease photo

Bloomberg: Pfizer, Allergan See Saunders as CEO

Drug makers Allergan PLC and Pfizer Inc. are eyeing a plan to make current Allergan Chief Executive Brent Saunders head of a combined company if they reach a takeover deal, Bloomberg Business reported today, citing unnamed sources.

Tease photo